跳至主要内容
临床试验/NCT02854969
NCT02854969已完成不适用

Randomized, Cross-over, Open, Unicentric Trial Evaluating Satisfaction With the Use of a Medical Device for the Epinephrine Auto-injector in Patients With Anaphylaxis

Adan Medical Innovation, SL2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Patient satisfaction through a questionnaire in the use of the medical device

研究概览

简要总结

Through several questionaries the investigators will measure the satisfaction of patients diagnosed with anaphylaxis in the use of a medical device for the adrenaline autoinjector, a smart case for an epinephrine autoinjector connected via Bluetooth to a mobile application.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years old or above
  • Patients diagnosed with Anaphylaxis and an epinephrine auto-injector prescribed
  • Patients with a smartphone
  • Patients who signed the informed consent

排除标准

  • Patients who have not signed the informed consent
  • Patients with some limitations for understanding or following correctly the trial procedures
  • Pregnant or nursing women

研究组 & 干预措施

epinephrine auto-injector

No Intervention

3 months using the epinephrine auto-injector alone, and after that 3 more months using the epinephrine auto-injector + medical device

epinephrine auto-injector + medical device

Experimental

Device: Anapphylaxis is a medical device with a case for an epinephrine autoinjector that connects via Bluetooth to a mobile application

3 months using the epinephrine auto-injector + medical device , and after that 3 more months using the epinephrine auto-injector alone

干预措施: Device: Anapphylaxis (Behavioral)

结局指标

主要结局

Patient satisfaction through a questionnaire in the use of the medical device

时间窗: 3 months

次要结局

  • Medical device safety(3 months)
  • Patient Adherence to the medical device through a questionnaire(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验